- Report
- April 2025
- 175 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- May 2024
- 128 Pages
Global
From €5915EUR$6,499USD£5,024GBP
Alphanate is a brand of hematological drugs used to treat a variety of blood disorders, including hemophilia, thrombocytopenia, and von Willebrand disease. It is a recombinant form of Factor VIII, a protein that helps the blood to clot. Alphanate is administered intravenously and is used to prevent and treat bleeding episodes in patients with hemophilia A. It is also used to prevent bleeding during surgery and to treat von Willebrand disease.
The Alphanate market is highly competitive, with a number of companies offering similar products. These companies include CSL Behring, Grifols, Octapharma, Pfizer, and Shire. Each company offers a range of products, including recombinant and plasma-derived Factor VIII, as well as other hematological drugs. These products are available in a variety of formulations, including intravenous, subcutaneous, and intramuscular. Show Less Read more